Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.

Cancer Med · 2020 · PMC6943166 · PMID 31701682

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

In an early exploratory analysis of RTOG 9802, the subgroup of patients with oligodendrogliomas showed the greatest benefit statistically in terms of benefit from PCV whereas the astrocytoma subgroup only showed a trend (but did not reach statistical significance).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.